Acute hearing loss

被引:22
作者
Tamhankar M. [1 ]
Solomon D. [1 ]
机构
[1] Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104
关键词
Hearing Loss; Cochlear Implant; Acoustic Neuroma; Anterior Inferior Cerebellar Artery; Sudden Sensorineural Hearing Loss;
D O I
10.1007/s11940-004-0039-y
中图分类号
学科分类号
摘要
Acute hearing loss (AHL) is a medical urgency. The management of patients presenting with sudden deafness involves detecting the causal mechanism and administering emergency therapeutic drugs to restore hearing by minimizing the period of cellular ischemia to the inner ear. Acute management of AHL consist of administering a 10-day course of high-dose corticosteroids (prednisone 60 to mg) until a cause can be established. Magnetic reasonance imaging with gadolinium is indicated, with a study dedicated to the internal auditory canals. The natural history of idiopathic AHL is characterized by spontaneous improvement in two thirds of patients. Maximum improvement occurs within 2 weeks of onset of AHL. In the vast majority of patients (>90%), the AHL is idiopathic. For an identifiable etiology, the treatment is specific and may consist of stopping ototoxic medications, repair of perilymphatic fistulas, administering antimicrobial agents for viral or bacterial infections, correction of metabolic imbalances, management of stroke, and possible surgery for cerebellopontine angle tumors. Management of idiopathic AHL is controversial. Various therapeutic agents, such as vasodilators, diuretics, anticoagulants, plasma expanders, contrast agents, and carbogen inhalation, have been tried in single therapy or as a combination therapy. The empiric use of these drugs is mainly based on improving the blood circulation and restoring the oxygen tension to the inner ear. The use of interventional procedures, such as low-density lipoprotein aphresis as well as newer drug delivery systems for corticosteroids, and immunosuppresive agents have opened new options in the treatment of AHL secondary to immune-mediated diseases if the inner ear. Prognosis for AHL is best when patients are seen early, begin recovery within 2 weeks, and have a mild hearing loss (>90 dB) with upward-sloping audiograms. Greater than 90 dB of hearing loss along with flat or down sloping audiogram, advanced age, and presence of vertigo are adverse prognostic factors for recovery of hearing loss. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:55 / 65
页数:10
相关论文
共 48 条
[1]  
Cole R.R., Jahrsdoerfer R.A., Sudden hearing loss: An update, Am. J. Otol., 9, pp. 211-215, (1988)
[2]  
Mattox D.E., Lyles C.A., Idiopathic sudden sensorineural hearing loss, Am. J. Otol., 10, pp. 242-247, (1989)
[3]  
Hughes G.B., Sudden sensorineural hearing loss, Otolaryngol. Clin. North Am., 29, pp. 393-405, (1996)
[4]  
Byl Jr. F.M., Sudden hearing loss: Eight years' experience and suggested prognostic table, Laryngoscope, 94, pp. 647-661, (1984)
[5]  
Wilson W.R., The relationship of the herpes virus family to sudden hearing loss: A prospective clinical study and literature review, Laryngoscope, 96, pp. 870-877, (1986)
[6]  
Schulz P., Highly variable distribution of HSV-1-specific DNA in human geniculate, vestibular and spiral ganglia, Neurosci. Lett., 252, pp. 139-142, (1998)
[7]  
Adour K.K., Otological complications of herpes zoster, Ann. Neurol., 35, SUPPL., (1994)
[8]  
Zoller M., Detection of syphilitic hearing loss, Arch. Otolaryngol., 104, pp. 63-65, (1978)
[9]  
Yaremchuk K., Dobie R.A., Otologic injuries from airbag deployment, Otolaryngol. Head Neck Surg., 125, pp. 130-134, (2001)
[10]  
McFeely Jr. W.J., Otologic injuries caused by airbag deployment, Otolaryngol. Head Neck Surg., 11, pp. 367-373, (1999)